- Home
- CROX vs HSIC Comparison
CROX vs HSIC Comparison
Compare CROX & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CROX
- HSIC
- Stock Information
- Founded
- CROX 1999
- HSIC 1932
- Country
- CROX United States
- HSIC United States
- Employees
- CROX N/A
- HSIC N/A
- Industry
- CROX Shoe Manufacturing
- HSIC Medical Specialities
- Sector
- CROX Consumer Discretionary
- HSIC Health Care
- Exchange
- CROX Nasdaq
- HSIC Nasdaq
- Market Cap
- CROX 8.3B
- HSIC 8.7B
- IPO Year
- CROX 2006
- HSIC 1995
- Fundamental
- Price
- CROX $99.97
- HSIC $73.22
- Analyst Decision
- CROX Buy
- HSIC Buy
- Analyst Count
- CROX 15
- HSIC 9
- Target Price
- CROX $146.21
- HSIC $79.56
- AVG Volume (30 Days)
- CROX 1.2M
- HSIC 1.0M
- Earning Date
- CROX 02-13-2025
- HSIC 02-25-2025
- Dividend Yield
- CROX N/A
- HSIC N/A
- EPS Growth
- CROX 27.09
- HSIC N/A
- EPS
- CROX 13.79
- HSIC 2.42
- Revenue
- CROX $4,072,432,000.00
- HSIC $12,499,000,000.00
- Revenue This Year
- CROX $4.94
- HSIC $6.16
- Revenue Next Year
- CROX $2.93
- HSIC $3.70
- P/E Ratio
- CROX $7.25
- HSIC $30.20
- Revenue Growth
- CROX 3.17
- HSIC N/A
- 52 Week Low
- CROX $94.50
- HSIC $63.67
- 52 Week High
- CROX $165.32
- HSIC $82.63
- Technical
- Relative Strength Index (RSI)
- CROX 31.70
- HSIC 57.16
- Support Level
- CROX $103.69
- HSIC $70.35
- Resistance Level
- CROX $108.70
- HSIC $72.44
- Average True Range (ATR)
- CROX 3.36
- HSIC 1.54
- MACD
- CROX -1.08
- HSIC 0.34
- Stochastic Oscillator
- CROX 3.39
- HSIC 94.20
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include the Americas, Asia Pacific, and EMEA.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.